Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines

MarketBeat

Biotechnology firm Moderna Inc. (NASDAQ: MRNA) made mainstream headlines during the pandemic for its COVID-19 vaccines. Moderna is focused on messenger RNA

1 week